미 FDA "화이자 백신, 긴급승인지침 부합"…미국도 접종 가시화<br /><br />The U.S. has confirmed that Pfizer's vaccine meets the standard for emergency use authorization in the country... saying it offers strong protection and does not raise any specific safety concerns.<br />A report issued by the FDA on Tuesday confirmed that the vaccine made by Pfizer and its German partner BioNTech appears to be 95-percent effective at preventing COVID-19 infection.<br />The reviewers found out that even after the first shot, people could be protected against severe illness... raising hopes that vaccination will begin soon.<br />The final decision will be made at a meeting on Thursday where the FDA’s independent advisers will debate if the evidence is strong enough to recommend vaccination to Americans.<br />